Agency Forms Undergoing Paperwork Reduction Act Review, 35360-35362 [2015-15128]
Download as PDF
<![CDATA[
35360
Federal Register / Vol. 80, No. 118 / Friday, June 19, 2015 / Notices
Office of Acquisition Policy, GSA, 202–
501–0650 or email edward.loeb@
gsa.gov.
SUPPLEMENTARY INFORMATION:
A. Purpose
B. Annual Reporting Burden
Respondents: 950.
Responses per Respondent: 10.
Annual Responses: 9,500.
Hours per Response: 1.
Total Burden Hours: 9,500.
C. Public Comments
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Centers for Disease Control and
Prevention
[30Day–15–15GE]
The clause at FAR 52.215–14,
Integrity of Unit Prices, requires offerors
and contractors under Federal contracts
that are to be awarded without adequate
price competition to identify in their
proposals those supplies which they
will not manufacture or to which they
will not contribute significant value.
The policies included in the FAR are
required by 41 U.S.C. 3503 (a)(1)(A)(for
the civilian agencies) and 10.U.S.C
2306a(b)(1)(A)(i)(for DOD and NASA).
The rule contains no reporting
requirements on contracts below the
simplified acquisition threshold,
construction and architect-engineering
services, utility services, service
contracts where supplies are not
required, commercial items, and
contracts for petroleum products.
Public comments are particularly
invited on: Whether this collection of
information is necessary; whether it will
have practical utility; whether our
estimate of the public burden of this
collection of information is accurate,
and based on valid assumptions and
methodology; ways to enhance the
quality, utility, and clarity of the
information to be collected; and ways in
which we can minimize the burden of
the collection of information on those
who are to respond, through the use of
appropriate technological collection
techniques or other forms of information
technology.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the General Services Administration,
Regulatory Secretariat Division (MVCB),
1800 F Street, NW., Washington, DC,
20405, telephone 202501–4755. Please
cite OMB Control No. 9000–0080,
Integrity of Unit Prices.
Dated: June 15, 2015.
Edward Loeb,
Acting Director, Federal Acquisition Policy
Division, Office of Governmentwide
Acquisition Policy, Office of Acquisition
Policy, Office of Governmentwide Policy.
[FR Doc. 2015–15131 Filed 6–18–15; 8:45 am]
BILLING CODE 6820–EP–P
VerDate Sep<11>2014
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
19:33 Jun 18, 2015
Jkt 235001
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Improving the Impact of Laboratory
Practice Guidelines: A New Paradigm
for Metrics—Clinical and Laboratory
Standards Institute—NEW —Center for
Surveillance, Epidemiology and
Laboratory Services (CSELS), Centers for
Disease Control and Prevention (CDC).
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) is funding three 5-year
projects collectively entitled ‘‘Improving
the Impact of Laboratory Practice
Guidelines: A New Paradigm for
Metrics’’. An ‘‘LPG’’ is defined as
written recommendations for voluntary,
standardized approaches for medical
laboratory testing that takes into account
processes for test selection, sample
procurement and processing, analytical
methods, and results reporting for
effective diagnosis and management of
disease and health conditions. LPGs
may be disseminated to, and used by,
laboratorians and clinicians to assist
with test selection and test result
interpretation. The overall purpose of
these cooperative agreements is to
increase the effectiveness of LPGs by
defining measures and collecting
information to inform better LPG
creation, revision, dissemination,
promotion, uptake, and impact on
clinical testing and public health. The
project will explore how these processes
and their impediments and facilitators
differ among various intended users of
LPGs. Through this demonstration
project, CDC seeks to understand how to
customize LPG creation and promotion
to better serve these intended users of
LPGs. An important goal is to help
organizations that sponsor the
development of LPGs create a
sustainable approach for continuous
quality improvement to evaluate and
improve an LPG’s impact through better
collection of information.
The CDC selected three organizations
that currently create and disseminate
LPGs to support activities under a
cooperative agreement funding
mechanism to improve the impact of
their LPGs. The American Society for
Microbiology (ASM), the Clinical and
Laboratory Standards Institute (CLSI),
and the College of American
Pathologists (CAP), will each use their
LPGs as models to better understand
how to improve uptake and impact of
these and future LPGs. Only the CLSI
submission will be described in this
notice.
Specifically, the CLSI project will
address two LPGs that are important to
clinical testing and have a high public
health impact: POCT12, Point-of-Care
Blood Glucose Testing in Acute and
Chronic Care Facilities and POCT13,
Glucose Monitoring in Settings without
Laboratory Support. These LPGs
provide guidance and recommendations
for personnel monitoring patient
glucose levels at sites that have access
to a hospital laboratory and at locations,
such as physician offices or nursing
E:\FR\FM\19JNN1.SGM
19JNN1
35361
Federal Register / Vol. 80, No. 118 / Friday, June 19, 2015 / Notices
homes, that do not have an on-site
moderate or high complexity laboratory.
It is expected that as a result of
sustained improvements in the process
of creating and updating these clinical
LPGs, public health, which depends
upon accurate and appropriate
laboratory testing guided by the use of
LPGs, will also generally benefit. The
intended users of the CLSI’s POCT12
and POCT13 LPGs will include point-ofcare coordinators, clinical laboratory
directors, medical technologists, nurses,
and medical doctors.
The CLSI plans to collect information
using the same survey instrument,
‘‘Fingerstick Glucose Survey’’ (FGS), on
three separate occasions. During the first
information collection (FGS1), all
targeted respondents will be asked to
complete the survey. Respondents who
indicate that they are not familiar with
either POCT12 or POCT13 will be asked
to provide an email address and offered
a free copy of the applicable LPG. This
subset of respondents will be asked to
complete the same survey (FGS2) 4–6
months after receiving the free LPG.
After analysis of the information
collected during the first 2 surveys,
CLSI will make improvements to
POCT12 and POCT13, such as provision
of educational materials or helpful
products such as quality control logs,
and may also alter their marketing
campaigns to address issues related to
awareness and use of CLSI documents.
The third survey (FGS3) will then be
sent to all targeted respondents
approximately 2.5 years after the first
survey to obtain information that can be
used to evaluate the impact of these
improvements. Respondents that
received a free copy of POCT12 or
POCT13 following the first survey will
also be contacted by email and asked to
take the third survey.
4–6 months after the initial survey and
will only target responders from the first
survey that received a complimentary
copy of one of the LPG documents. CLSI
anticipates that approximately 12,000
participants will be asked to take the
second survey. Approximately two and
a half years after the initial survey, the
same survey will be sent to the same
laboratories as the first survey (i.e. we
will solicit approximately 30,000
potential respondents and expect about
24,000 individuals to take the survey).
The third survey will measure the
impact of the modifications to the
documents and marketing strategy made
based on the data collected from the
first 2 surveys. The response rate for all
surveys will be maximized by repeated
reminders using the same channel that
will be used to distribute the survey. All
targeted laboratories will receive an
email or postcard approximately one
month before distribution of the survey.
This letter will describe the survey and
our purpose for collecting information.
Another email or postcard with a link to
the survey will then be sent to the same
targeted laboratories. We also plan to
resend the link to the survey to all
targeted laboratories approximately one
month later to remind them of the
survey.
The CLSI believes completion of the
survey will take approximately 15
minutes. The survey will be pilot tested
with 9 or fewer respondents before
deployment to assure that they require
15 minutes or less to complete.
The total estimated annualized
burden is 6,173 hours. This is calculated
by dividing the total burden hours by
the number of years (three) over which
data is collected. The maximum burden
is 7,407 hours that occurs in years 1 and
3.
There are no costs to respondents
other than their time.
A link to the survey will be
distributed to all targeted respondents
either by email or postcard. The CLSI
will solicit participation from physician
office laboratories, Department of
Defense laboratories, and hospitals that
offer point-of-care glucose testing.
Participants will be recruited by COLA,
the Joint Commission and a Point-ofCare Coordinator network, who have
agreed to distribute links to the survey
through their membership mailing lists.
In addition, participants will also be
solicited through mailing lists
purchased by CLSI from Clinscan and
the American Hospital Association.
Clinical sites offering point-of-care
glucose testing in the Department of
Defense medical system will also be
asked to participate through the
Department of Defense Clinical
Laboratory Improvement Program
(CLIP). In order to obtain the needed
number of respondents for a statistically
valid study, additional laboratories,
selected at random from a database of
Clinical Laboratory Improvement
Amendment (CLIA) certificate holders,
will also be solicited. The survey will
contain instructions to direct it to the
individual in each laboratory
responsible for the development or
revision of procedures for fingerstick
glucose testing. Directing the survey to
the individual with this specific
responsibility will help to ensure that
only one response will be obtained from
each participating laboratory.
Respondents include point-of-care
coordinators, clinical laboratory
directors, managers, and supervisors,
medical technologists, nurses, and
medical doctors.
The CLSI hopes to achieve an 80%
response rate with their laboratory
information collections, or 24,000 out of
about 30,000 potential respondents. The
second survey will occur approximately
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Form name
Point-of-Care Coordinators ..............................................................................
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Laboratory Directors ........................................................................................
Laboratory Managers .......................................................................................
Laboratory Supervisors ....................................................................................
Medical Technologists .....................................................................................
VerDate Sep<11>2014
19:33 Jun 18, 2015
Jkt 235001
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
Number
of respondents
Number of
responses per
respondent
500
250
500
4,276
2,138
4,276
4,276
2,138
4,276
4,276
2,138
4,276
7,800
3,900
7,800
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
FGS1
FGS2
FGS3
FGS1
FGS2
FGS3
FGS1
FGS2
FGS3
FGS1
FGS2
FGS3
FGS1
FGS2
FGS3
E:\FR\FM\19JNN1.SGM
19JNN1
Average
burden per
response
(in hours)
15/60
15/60
15/60
15/60
15/60
15/60
15/60
15/60
15/60
15/60
15/60
15/60
15/60
15/60
15/60
35362
Federal Register / Vol. 80, No. 118 / Friday, June 19, 2015 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent
Form name
Nurses ..............................................................................................................
Medical Doctors ...............................................................................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–15128 Filed 6–18–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10141 and CMS–
10540]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
ACTION:
Notice.
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:33 Jun 18, 2015
Jkt 235001
Number
of respondents
Number of
responses per
respondent
5,000
2,500
5,000
3,500
1,750
3,500
1
1
1
1
1
1
FGS1
FGS2
FGS3
FGS1
FGS2
FGS3
Comments on the collection(s) of
information must be received by the
OMB desk officer by July 20, 2015.
ADDRESSES: When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
following transmissions: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–5806, or Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
Reports Clearance Office at (410) 786–
1326.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
DATES:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
Average
burden per
response
(in hours)
15/60
15/60
15/60
15/60
15/60
15/60
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicare
Prescription Drug Benefit Program; Use:
Part D plans and, to the extent
applicable, MA organizations use the
information to comply with the
eligibility and associated Part D
participating requirements. We use this
information to approve contract
applications, monitor compliance with
contract requirements, make proper
payment to plans, and to ensure that
correct information is disclosed to
potential and current enrollees. Form
Number: CMS–10141 (OMB control
number 0938–0964); Frequency: Once;
Affected Public: Private sector (Business
or other for-profit and Not-for-profit
institutions); Number of Respondents:
4,101,066; Total Annual Responses:
46,099,944; Total Annual Hours:
7,572,223. (For policy questions
regarding this collection contact
Deborah Larwood at 410–786–9500).
2. Type of Information Collection
Request: New collection (Reqeust for a
new OMB control number); Title of
Information Collection: Quality
Improvement Strategy Implementation
Plan and Progress Report; Use: Section
1311(c)(1)(E) of the Affordable Care Act
requires qualified health plans (QHPs)
offered through an Exchange must
implement a quality improvement
strategy (QIS) as described in section
1311(g)(1). Section 1311(g)(3) of the
Affordable Care Act specifies the
guidelines under Section 1311(g)(2)
shall require the periodic reporting to
the applicable Exchange the activities
that a qualified health plan has
conducted to implement a strategy as
described in section 1311(g)(1). We
intend to have QHP issuers complete
the QIS Plan and Reporting Template
annually for initial certification and
subsequent annual updates of progress
in implementation of their strategy. The
E:\FR\FM\19JNN1.SGM
19JNN1
]]>Agencies
[Federal Register Volume 80, Number 118 (Friday, June 19, 2015)]
[Notices]
[Pages 35360-35362]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-15128]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-15-15GE]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Improving the Impact of Laboratory Practice Guidelines: A New
Paradigm for Metrics--Clinical and Laboratory Standards Institute--NEW
--Center for Surveillance, Epidemiology and Laboratory Services
(CSELS), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC) is funding
three 5-year projects collectively entitled ``Improving the Impact of
Laboratory Practice Guidelines: A New Paradigm for Metrics''. An
``LPG'' is defined as written recommendations for voluntary,
standardized approaches for medical laboratory testing that takes into
account processes for test selection, sample procurement and
processing, analytical methods, and results reporting for effective
diagnosis and management of disease and health conditions. LPGs may be
disseminated to, and used by, laboratorians and clinicians to assist
with test selection and test result interpretation. The overall purpose
of these cooperative agreements is to increase the effectiveness of
LPGs by defining measures and collecting information to inform better
LPG creation, revision, dissemination, promotion, uptake, and impact on
clinical testing and public health. The project will explore how these
processes and their impediments and facilitators differ among various
intended users of LPGs. Through this demonstration project, CDC seeks
to understand how to customize LPG creation and promotion to better
serve these intended users of LPGs. An important goal is to help
organizations that sponsor the development of LPGs create a sustainable
approach for continuous quality improvement to evaluate and improve an
LPG's impact through better collection of information.
The CDC selected three organizations that currently create and
disseminate LPGs to support activities under a cooperative agreement
funding mechanism to improve the impact of their LPGs. The American
Society for Microbiology (ASM), the Clinical and Laboratory Standards
Institute (CLSI), and the College of American Pathologists (CAP), will
each use their LPGs as models to better understand how to improve
uptake and impact of these and future LPGs. Only the CLSI submission
will be described in this notice.
Specifically, the CLSI project will address two LPGs that are
important to clinical testing and have a high public health impact:
POCT12, Point-of-Care Blood Glucose Testing in Acute and Chronic Care
Facilities and POCT13, Glucose Monitoring in Settings without
Laboratory Support. These LPGs provide guidance and recommendations for
personnel monitoring patient glucose levels at sites that have access
to a hospital laboratory and at locations, such as physician offices or
nursing
[[Page 35361]]
homes, that do not have an on-site moderate or high complexity
laboratory. It is expected that as a result of sustained improvements
in the process of creating and updating these clinical LPGs, public
health, which depends upon accurate and appropriate laboratory testing
guided by the use of LPGs, will also generally benefit. The intended
users of the CLSI's POCT12 and POCT13 LPGs will include point-of-care
coordinators, clinical laboratory directors, medical technologists,
nurses, and medical doctors.
The CLSI plans to collect information using the same survey
instrument, ``Fingerstick Glucose Survey'' (FGS), on three separate
occasions. During the first information collection (FGS1), all targeted
respondents will be asked to complete the survey. Respondents who
indicate that they are not familiar with either POCT12 or POCT13 will
be asked to provide an email address and offered a free copy of the
applicable LPG. This subset of respondents will be asked to complete
the same survey (FGS2) 4-6 months after receiving the free LPG. After
analysis of the information collected during the first 2 surveys, CLSI
will make improvements to POCT12 and POCT13, such as provision of
educational materials or helpful products such as quality control logs,
and may also alter their marketing campaigns to address issues related
to awareness and use of CLSI documents. The third survey (FGS3) will
then be sent to all targeted respondents approximately 2.5 years after
the first survey to obtain information that can be used to evaluate the
impact of these improvements. Respondents that received a free copy of
POCT12 or POCT13 following the first survey will also be contacted by
email and asked to take the third survey.
A link to the survey will be distributed to all targeted
respondents either by email or postcard. The CLSI will solicit
participation from physician office laboratories, Department of Defense
laboratories, and hospitals that offer point-of-care glucose testing.
Participants will be recruited by COLA, the Joint Commission and a
Point-of-Care Coordinator network, who have agreed to distribute links
to the survey through their membership mailing lists. In addition,
participants will also be solicited through mailing lists purchased by
CLSI from Clinscan and the American Hospital Association. Clinical
sites offering point-of-care glucose testing in the Department of
Defense medical system will also be asked to participate through the
Department of Defense Clinical Laboratory Improvement Program (CLIP).
In order to obtain the needed number of respondents for a statistically
valid study, additional laboratories, selected at random from a
database of Clinical Laboratory Improvement Amendment (CLIA)
certificate holders, will also be solicited. The survey will contain
instructions to direct it to the individual in each laboratory
responsible for the development or revision of procedures for
fingerstick glucose testing. Directing the survey to the individual
with this specific responsibility will help to ensure that only one
response will be obtained from each participating laboratory.
Respondents include point-of-care coordinators, clinical laboratory
directors, managers, and supervisors, medical technologists, nurses,
and medical doctors.
The CLSI hopes to achieve an 80% response rate with their
laboratory information collections, or 24,000 out of about 30,000
potential respondents. The second survey will occur approximately 4-6
months after the initial survey and will only target responders from
the first survey that received a complimentary copy of one of the LPG
documents. CLSI anticipates that approximately 12,000 participants will
be asked to take the second survey. Approximately two and a half years
after the initial survey, the same survey will be sent to the same
laboratories as the first survey (i.e. we will solicit approximately
30,000 potential respondents and expect about 24,000 individuals to
take the survey). The third survey will measure the impact of the
modifications to the documents and marketing strategy made based on the
data collected from the first 2 surveys. The response rate for all
surveys will be maximized by repeated reminders using the same channel
that will be used to distribute the survey. All targeted laboratories
will receive an email or postcard approximately one month before
distribution of the survey. This letter will describe the survey and
our purpose for collecting information. Another email or postcard with
a link to the survey will then be sent to the same targeted
laboratories. We also plan to resend the link to the survey to all
targeted laboratories approximately one month later to remind them of
the survey.
The CLSI believes completion of the survey will take approximately
15 minutes. The survey will be pilot tested with 9 or fewer respondents
before deployment to assure that they require 15 minutes or less to
complete.
The total estimated annualized burden is 6,173 hours. This is
calculated by dividing the total burden hours by the number of years
(three) over which data is collected. The maximum burden is 7,407 hours
that occurs in years 1 and 3.
There are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hours)
--------------------------------------------------------------------------------------------------
Point-of-Care Coordinators........ FGS1 500 1 15/60
FGS2 250 1 15/60
FGS3 500 1 15/60
Laboratory Directors.............. FGS1 4,276 1 15/60
FGS2 2,138 1 15/60
FGS3 4,276 1 15/60
Laboratory Managers............... FGS1 4,276 1 15/60
FGS2 2,138 1 15/60
FGS3 4,276 1 15/60
Laboratory Supervisors............ FGS1 4,276 1 15/60
FGS2 2,138 1 15/60
FGS3 4,276 1 15/60
Medical Technologists............. FGS1 7,800 1 15/60
FGS2 3,900 1 15/60
FGS3 7,800 1 15/60
[[Page 35362]]
Nurses............................ FGS1 5,000 1 15/60
FGS2 2,500 1 15/60
FGS3 5,000 1 15/60
Medical Doctors................... FGS1 3,500 1 15/60
FGS2 1,750 1 15/60
FGS3 3,500 1 15/60
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-15128 Filed 6-18-15; 8:45 am]
BILLING CODE 4163-18-P
